You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

Use of Preoperative Chemotherapy With or Without Postoperative Radiotherapy in Technically Resectable Stage IIIA Non-Small Cell Lung Cancer

Version: 2 ID: 7-4 déc 2017
Type of Content: Guidelines & Advice, Clinical
Document Status: Archived
Authors:
Lung Cancer Disease Site Group

Patient Population

Adult patients with technically resectable Stage IIIA NSCLC, as determined by a thoracic surgeon.

Research Question(s)

Should preoperative (neoadjuvant) cisplatin-based chemotherapy, with or without postoperative radiotherapy, be offered to patients with technically resectable stage IIIA nonsmall cell lung cancer (NSCLC), in order to improve survival? Resectability should be determined preoperatively by a thoracic surgeon.

pdf download Full Report (PDF) (1.07 Mo)